With survival rates still low, NodeAI’s deep-learning tool could double the accuracy of a crucial cancer test — and cut costs ...

When the patient opted against surveillance CT scans and a follow-up PET scan, her physician ordered the CyPath® Lung test in March 2025. The test result of 0.56 – classified as “likely malignancy” – ...

Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.